Tue, Jul 22, 2014, 8:27 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Hyperion Therapeutics, Inc. (HPTX) Message Board

  • rrtzrealmd rrtzrealmd May 7, 2013 10:15 AM Flag

    HAW!!!...yeah, you can tell that HPTX's...

    ....competition is just raking in the dough by looking at their elaborate websites...yahoo won't let me hotlink but you can google and find the "tributyrate" website where it proclaims:

    "triButyrate is the trade name for (Sodium) Phenylbutyrate (or 4-phenylbutyric acid sodium salt). triButyrate was originally developed in the mid 1980's by triple crown america, inc. at the request of Johns Hopkins Hospital as a remedy for inborn errors of urea synthesis (Urea Cycle Disorder). For this indication triButyrate/(Sodium) Phenylbutyrate is today the Active Pharmaceutical Ingredient (API) of the registered drug to treat Urea Cycle Disorder in the United States of America."

    ...they been selling the stuff for THIRTY YEARS and that's the best website design they can offer?!...HAW!!!...

    ...but it gets worse -- google "triplecrownamerica" and look at the same cheesy looking website design where its other subsidiaries "eurohealth" and "totaloralhygiene" sell such advanced products as DHEA and melatonin!...HAW!!!...

    ....and just THINK!...that's AFTER thirty YEARS of selling "tributyrate"!!!...yeah, baby, no doubt they're just rollin' in the dough!...

    ...shades of HPTX's future perhaps?...HAW, HAW, HAW!!!...

    Sentiment: Strong Sell

 
HPTX
24.41+0.05(+0.21%)Jul 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.